← Browse by Condition
Medical Condition

inflammatory bowel disease

Total Trials
10
Recruiting Now
10
Trial Phases
Phase 2, Phase 1

ClinicalMetric tracks all active clinical trials for inflammatory bowel disease sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — inflammatory bowel disease Clinical Trials

How many clinical trials are currently recruiting for inflammatory bowel disease?
ClinicalMetric currently tracks 10 actively recruiting clinical trials for inflammatory bowel disease, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 10. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for inflammatory bowel disease?
inflammatory bowel disease research spans Phase 1 (1 trial), Phase 2 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a inflammatory bowel disease clinical trial?
Eligibility criteria for inflammatory bowel disease trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 1
1
Phase 2
1
Top Sponsors
Stanford University 1 trial
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 1 trial
Janssen-Cilag Ltd. 1 trial
University Hospital, Clermont-Ferrand 1 trial
Fang Tang 1 trial

Recruiting Clinical Trials

NCT03615690
Recruiting
The Influence of a Fasting Mimicking Diet on Ulcerative Colitis
Enrollment
75 pts
Location
United States
Sponsor
Stanford University
View Trial →
NCT07619547
Recruiting
Longitudinal Immunophenotyping of Patients With Inflammatory Bowel Disease
Enrollment
100 pts
Location
United States
Sponsor
National Institute of Diabetes...
View Trial →
NCT07242248
Recruiting
A Study to Observe Real-world Evidence of Guselkumab Treatment in Participants With Ulcerative Colitis and Crohn's Disease in the United Kingdom (UK)
Enrollment
220 pts
Location
United Kingdom
Sponsor
Janssen-Cilag Ltd.
View Trial →
NCT03913962
Recruiting
Health and Exercise Response in Children With Chronic and Auto-immune Pathologies
Enrollment
300 pts
Location
France
Sponsor
University Hospital, Clermont-...
View Trial →
NCT07252427
Recruiting
Gut Microbiota in IBD With Comorbid Depressive Disorder
Enrollment
120 pts
Location
China
Sponsor
Fang Tang
View Trial →
NCT06001450
Recruiting
Pregnant Women With and Without Crohns Disease to Explore the Role of Plastics and Toxins in Intestinal Inflammation
Enrollment
46 pts
Location
United States
Sponsor
Icahn School of Medicine at Mo...
View Trial →
NCT06780683
Recruiting
Efficacy and Safety of Upadacitinib in Inflammatory Bowel Disease
Enrollment
174 pts
Location
China
Sponsor
Xiang Gao
View Trial →
NCT07814456 Phase 2
Recruiting
Fecal Microbiota Transplantation for Ulcerative Colitis Using Dai and Han Donors
Enrollment
200 pts
Location
China
Sponsor
First Affiliated Hospital of K...
View Trial →
NCT04331639
Recruiting
High Dose Interval Vitamin D Supplementation in Patients With Inflammatory Bowel Disease Receiving Biologic Therapy
Enrollment
50 pts
Location
United States
Sponsor
Boston Children's Hospital
View Trial →
NCT03816345 Phase 1
Recruiting
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
Enrollment
300 pts
Location
United States, Canad...
Sponsor
National Cancer Institute (NCI...
View Trial →

Related Conditions

ulcerative colitis (5) crohn s disease (3) crohn disease (2) diet modification (1) colitis ulcerative (1) juvenile idiopathic arthritis (1) diabetes (1) cancer survivor (1) anorexia nervosa (1) depressive disorder (1) crohns disease (1) pregnancy (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology